Arab Pharmaceuticals

مادة اعلانية

Latest Update: 2 Feb 2026 16:28 Abu Dhabi Time.

Market Status: Closed

ADCI

Arab Pharmaceuticals

160.48

EGP

1.790

1.13%

Open

158.69

Prev Close

158.69

PX_VOLUME

24,500

MARKET CAP (M)

DAY RANGE

159.10 - 164.94

52 WEEKS

68.64 - 249.98

Stock Statistics

Yearly Change

127.00%

Listed Shares (Million)

12.00

Earnings Multiple

7.51

Average 30-day trading volume

29,715.84

Price-to-book ratio

3.45

Earnings Per Share

18.99

Previous Dividend Distribution

7.92

Dividend Yield

5.25%

Financial Summary

Quarterly
Annual

Income Statements

	Period Ending:	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Total Revenue		306.02	296.76	263.29	324.80	233.33	204.44	167.19	222.66	191.24
Gross Profit		124.36	119.10	109.95	142.60	94.63	68.62	44.23	87.45	65.69
Operating Income		93.32	86.34	84.45	95.80	48.16	23.44	10.37	45.64	33.77
Profit Margin		20.27	21.29	22.28	21.46	15.56	9.94	10.06	17.19	14.34

	Period Ending:	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Total Revenue		1,118.18	785.52	633.73	505.04	537.05
Gross Profit		466.28	265.99	224.35	185.43	230.30
Operating Income		314.74	118.10	94.76	89.82	122.16
Profit Margin		20.38	13.09	13.06	15.11	18.88

Balance Sheet

	Period Ending:	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Total Assets		1,399.33	1,322.89	1,266.46	1,215.16	1,198.23	1,133.59	1,100.14	1,057.19	732.60
Total Liabilities		847.45	703.15	706.28	713.65	766.75	675.06	657.93	645.23	321.95
Total Equity		551.88	619.74	560.18	501.51	431.48	458.53	442.21	411.96	410.65

	Period Ending:	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Total Assets		1,322.89	1,133.59	682.07	573.98	446.27
Total Liabilities		703.15	675.06	298.84	233.78	136.63
Total Equity		619.74	458.53	383.23	340.21	309.63

Cash Flows Statements - Coming Soon

* In Million of Egypt Pound

Reminder: The financial information on this website is delayed information that are originates from certified data providers in the financial markets, who retain the rights and intellectual property of this data, absolving ADMN of any responsibility.